Eterna Therapeutics Inc.

NasdaqCM:ERNA Stock Report

Market Cap: US$12.8m

Eterna Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ERNA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2040.000397%
VC/PE Firms5,136,68610%
Institutions5,146,61610%
General Public16,115,13031.4%
Individual Insiders24,976,07748.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 849.6%.

Top Shareholders

Top 25 shareholders own 68.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
32.4%
Charles Cherington
16,642,183US$4.1m2,890%no data
10%
Freebird Partners LP
5,136,686US$1.3m1,780%99.99%
9.77%
John Halpern
5,021,571US$1.3m1,010%no data
7.97%
Purchase Capital LLC
4,095,436US$1.0m0%no data
5.22%
David Laughlin
2,679,214US$667.1k1,160%no data
0.89%
George Denny
457,442US$113.9k0%no data
0.52%
Pacific Premier Bancorp Inc, Asset Management Arm
266,214US$66.3k0%no data
0.51%
Corient Private Wealth LLC
262,862US$65.5k422%no data
0.34%
Matthew Angel
174,482US$43.4k0%no data
0.18%
Cypress Point Wealth Management, LLC
94,375US$23.5k0%0.01%
0.16%
UBS Asset Management AG
83,620US$20.8k0%no data
0.15%
Naviter Wealth LLC
78,796US$19.6k0%no data
0.14%
Lincoln Park Capital, LLC
73,659US$18.3k0%1.06%
0.13%
Sippican Capital Advisors LLC
68,504US$17.1k-5.9%0.01%
0.064%
Two Sigma Securities, LLC, Asset Management Arm
32,860US$8.2k0%no data
0.051%
The Vanguard Group, Inc.
26,099US$6.5k0%no data
0.04%
Geode Capital Management, LLC
20,435US$5.1k-13.9%no data
0.029%
BlackRock, Inc.
14,919US$3.7k-0.36%no data
0.029%
Avidian Wealth Enterprises, LLC
14,798US$3.7k0%no data
0.017%
Baldwin Wealth Partners, LLC
8,544US$2.1k0%no data
0.0097%
Tower Research Capital Europe Limited
4,994US$1.2k-3.48%no data
0.0023%
Sandra Gurrola
1,185US$295.50%no data
0.00041%
A. Montag & Associates, Inc.
212US$52.40%no data
0.0004%
Estate of George Denny
204US$51.20%no data
0.00024%
Bank of America Corporation, Asset Management Arm
123US$30.7324%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 05:47
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eterna Therapeutics Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristen KluskaCantor Fitzgerald & Co.
Jason McCarthyMaxim Group